489 related articles for article (PubMed ID: 2370293)
21. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy.
Hamon P; Bovier-Lapierre M; Robert M; Peynaud D; Pugeat M; Orgiazzi J
J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960
[TBL] [Abstract][Full Text] [Related]
22. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.
Wynne AG; Gharib H; Scheithauer BW; Davis DH; Freeman SL; Horvath E
Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235
[TBL] [Abstract][Full Text] [Related]
23. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
Gershengorn MC; Weintraub BD
J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
[TBL] [Abstract][Full Text] [Related]
24. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3].
Sorger D; Schenk S; Schneider G
Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism.
Gharib H; Carpenter PC; Scheithauer BW; Service FJ
Mayo Clin Proc; 1982 Sep; 57(9):556-63. PubMed ID: 7109684
[TBL] [Abstract][Full Text] [Related]
26. Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995.
Beck-Peccoz P; Medri G; Piscitelli G; Mariotti S; Bertoli A; Barbarino A; Rondena M; Martino E; Pinchera A; Faglia G
Horm Res; 1988; 29(2-3):121-3. PubMed ID: 2900192
[TBL] [Abstract][Full Text] [Related]
27. [Metabolic evaluation and etiology of "preclinical hypothyroidism": a preliminary report].
Gräni R; Staub JJ; Bechtel M; Müller J; Girard J; Stähelin HB; Burckhardt D
Schweiz Med Wochenschr; 1981 Jan; 111(5):142-6. PubMed ID: 7197052
[TBL] [Abstract][Full Text] [Related]
28. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
Nedvídková J; Felt V
Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
[TBL] [Abstract][Full Text] [Related]
30. 3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.
Kunitake JM; Hartman N; Henson LC; Lieberman J; Williams DE; Wong M; Hershman JM
J Clin Endocrinol Metab; 1989 Aug; 69(2):461-6. PubMed ID: 2753985
[TBL] [Abstract][Full Text] [Related]
31. Characterization of sex hormone-binding globulin isoforms in hypothyroid women.
Brenta G; Bedecarras P; Schnitman M; Gurfinkiel M; Damilano S; Campo S; Pisarev MA
Thyroid; 2002 Feb; 12(2):101-5. PubMed ID: 11916278
[TBL] [Abstract][Full Text] [Related]
32. Normal serum concentrations of sex hormone binding-globulin in patients with hyperthyroidism due to subacute thyroiditis.
Vierhapper H; Bieglmayer C; Nowotny P; Waldhäusl W
Thyroid; 1998 Dec; 8(12):1107-11. PubMed ID: 9920365
[TBL] [Abstract][Full Text] [Related]
33. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin.
Terzolo M; Orlandi F; Bassetti M; Medri G; Paccotti D; Cortelazzi D; Angeli A; Beck-Peccoz P
J Clin Endocrinol Metab; 1991 Feb; 72(2):415-21. PubMed ID: 1704010
[TBL] [Abstract][Full Text] [Related]
34. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood.
Rondeel JM; de Greef WJ; van der Schoot P; Karels B; Klootwijk W; Visser TJ
Endocrinology; 1988 Jul; 123(1):523-7. PubMed ID: 3133200
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
[TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β.
Macchia E; Lombardi M; Raffaelli V; Piaggi P; Macchia L; Scattina I; Martino E
Clin Endocrinol (Oxf); 2014 Dec; 81(6):921-8. PubMed ID: 25040256
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine.
Zulewski H; Siggelkow H; Walden C; Becker W; Hüfner M
Exp Clin Endocrinol Diabetes; 1999; 107(3):190-4. PubMed ID: 10376444
[TBL] [Abstract][Full Text] [Related]
38. Interpretation of sex hormone-binding globulin levels in thyroid disorders.
Hampl R; Kancheva R; Hill M; Bicíková M; Vondra K
Thyroid; 2003 Aug; 13(8):755-60. PubMed ID: 14558918
[TBL] [Abstract][Full Text] [Related]
39. Abnormally high TSH in subject with thyrotoxicosis affected by congenital hypothyroidism. Case report.
Alberto G; Novi RF; Trombetta A; Maurino M; Seardo MA; Brossa C; Messina M
Minerva Endocrinol; 2000 Mar; 25(1):29-32. PubMed ID: 11148847
[TBL] [Abstract][Full Text] [Related]
40. Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level.
Faber J; Perrild H; Johansen JS
J Clin Endocrinol Metab; 1990 Jan; 70(1):49-55. PubMed ID: 2294139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
